What medium are you using for your COVID-19 research?
Bucks pharma company Lampire expanding operations
by Anthony Salamone, Contact Reporter Of The Morning Call
Bucks County life-sciences company Lampire Biological Laboratories has expanded its operations by acquiring a 179-acre farm in Bedford County.
The company recently closed on the farm near Everett, Bedford County, for $1.15 million, including renovations, company President and CEO Gregory Krug said Thursday. The farm which complements its previous acquisition of 400 acres in the same area. Lampire, which also operates a laboratory in Coopersburg, plans to increase production by handling additional animals needed to produce biological materials used for drug testing and diagnostic and research use.
Gov. Tom Wolf’s administration announced this week that officials approved a $400,000 low-interest loan toward the farm purchase for Lampire, which is headquartered off Route 611 in Bedminister Township. The 15-year, 3.75 percent loan received approvals through the Pennsylvania Industrial Development Authority and the Bedford County Development Association.
Michael Gerber, a spokesman with the state Department of Community and Economic Development, said Lampire’s farm acquisition is not tied to job creation or retention. But privately owned Lampire, which was founded about 40 years ago, has been growing. It employs 137 people at six facilities in Pennsylvania. The company makes raw materials, such as serums and antibodies, drawn from animals, that are used by the diagnostic, biotechnological and pharmaceutical industries.
Separately, Lampire said it has started production of a new product: lobster hemocyanin. A protein found in lobsters and related animals, specialized hemocyanins, have a range of uses in the biomedical field, according to Lobster Unlimited of Brewer, Maine, which is partnering with Lampire on the product. Krug said the origin of the lobster hemocyanin project was a collaboration between Lampire and scientists at the University of Maine.
Lehigh Valley Economic Development Corp. has targeted life-science research and manufacturing, including the pharmaceutical industry, as one of four sectors with great potential for growth in the region. A recent talent supply study from LVEDC says nearly 10,400 people work in the sector, with the number expected to grow by 565 jobs in 2022.
The Valley’s existing medical supply and medical diagnostics presence, including OraSure Technologies and B. Braun Medical, its access to talent from local universities that could support the research and development, and proximity to pharmaceutical companies in suburban Philadelphia and New Jersey are among the reasons behind the anticipated growth.
Click here for online article.
asalamone@mcall.com
610-820-6694
Lampire Biological Laboratories Acquires Additional Production Facility in Bedford County
FOR IMMEDIATE RELEASE – September 26, 2018
In August of 2018, with the support of the Bedford County Development Association (BCDA) and the Pennsylvania Industrial Development Association (PIDA), LAMPIRE Biological Laboratories acquired an 180+ acre corporate dairy farm located adjacent to the existing corporate farm facilities in Bedford County, Pennsylvania. PIDA provides low-interest loans and lines of credit for eligible businesses that commit to creating and retaining full-time jobs in Pennsylvania. Funding may be used for land and building, construction and renovation costs, machinery and equipment purchases, to name a few. A variety of different industry sectors are eligible for PIDA financing including manufacturing, industrial, agricultural, research and development and many others.
LAMPIRE Biological Laboratories has earned primary vendor status with pharmaceutical, diagnostic, biotechnology and medical device corporations worldwide. Commitment to quality and customer service has established Lampire as a key resource for clients through the research and development, scale-up and optimization stages of product development and subsequent production. Lampire also serves academia and government research agencies involved in the areas of immunology, cell biology, cell signaling, pathology, molecular biology and clinical medicine. This purchase was essential to support Lampire’s growing operational needs.
In addition to adding over 180+ acres of planting and pasturing property to the Lampire holdings, this real estate acquisiton offers over 30,000 square feet of barns and utility space. Lampire intends to house expanding goat and llama populations at the new farm. As the new facility undergoes retrofitting to make it compliant with stringent industry standards, additional vivariums for animal care will become available. Lampire is recognized for their wide array of species available for the production of biological materials used for drug testing, biological warfare and the manufacturing of raw materials for diagnostic and research use. With bordering property lines to the current Lampire farm, this conveniently situated space in Everett will also be used for making and banking hay and storing equipment. Also, due to the condition, accessibility and size of the outbuildings, this property will serve as the maintenance shop for the 600+ acres of Everett farm facilities.
Founded in Doylestown, PA in 1977, Lampire Biological Laboratories has grown exponentially over the years. Through hard work and determination on the part of co-founder and owner, President and CEO, Gregory F. Krug, Lampire has transformed from a local raw biological product supplier to a global manufacturer of a large variety of biological blood products, reagents, immunochemicals, custom antibodies and many other products and services.
This property acquisition is the latest along the timeline of strategic growth for Lampire. Starting with forty acres in Bucks County, Krug and his team set out to acquire and retrofit laboratory facilities to meet this highly regulated research related industry. The first of these facilities opened in 1986. Next, in 1989, with just over a decade on the books, Lampire acquired property to expand operations and established themselves in the western part of Pennsylvania. After another ten years, back in eastern PA, the 18,000 square foot Biotech Research and Resource Center was opened for business. Turn the clock ten years later to 2007, where renovation to an existing industrial space resulted in a state-of-the-art laboratory opening in Everett, PA. This facility was designed to support the expanding farm facilities located in Western, PA. Including this latest acquisition, the current landscape at Lampire encompasses over 130 employees, three cutting edge laboratory facilities and three production farm properties.
Not one to shy away from a challenge, Gregory F. Krug credits the growth of Lampire to being willing to take calculated risks and trusting in his mentors who have successfully guided him along his path to success. “This road has had many bumps and turns, Lampire would not be the company we are today, if not for the help of many people, especially the team at the BCDA, Bette Slayton, Terri Brumbaugh and Melanie Miller. This group was instrumental in helping Lampire secure property and settle in Bedford County in the early 1990s. Over the years, it has been my privilege to have been able to give back to our community as an advocate for technical workforce development in the life sciences. We actively work with the local schools to encourage the young people of Bedford County to seek employment right here. It has also been my privilege to have served as a
volunteer with the BCDA for over 20 years. Once again, almost 30 years later, their efforts have helped Lampire expand in Bedford County through the cooperative efforts of the BCDA, PIDA and the state of Pennsylvania. We hope to continue to provide job opportunities and valuable biological raw materials to diagnostic and research companies around the world, for many, many years to come.”
Small Business Spotlight: Lampire Biological Laboratories, Inc.
y PA Dept of Community and Economic Development – PA Proud Blog
Lampire Biological Laboratories, Inc., is a biotechnology company that has several locations across Pennsylvania. We spoke to Gregory F. Krug, CEO of Lampire, about his contributions to the life sciences industry and how recent funding through the Pennsylvania Industrial Development Authority (PIDA) will help his business continue to grow.
How did Lampire get its start?
Lampire’s story began when… READ MORE
Global Bovine Serum Albumin Market Top Players 2017: Lampire Biological Laboratories…
by Lori Lobato; The Herald Analyst
Global Bovine Serum Albumin Market Top Players 2017: Lampire Biological Laboratories, Proliant Inc and Thermo Fisher Scientific Inc.
The Global Bovine Serum Albumin Market Report elaborates the complete details of latest industry trends and business circumstances to help the Bovine Serum Albumin market aspirants in making key business decisions. All the vital aspects of Bovine Serum Albumin like the current developments, growth opportunities, Bovine Serum Albumin industry chain structure, applications are covered in this report. Global Bovine Serum Albumin report also conducts the regional analysis of Bovine Serum Albumin market based on market size, manufacturing cost, key market players and their Bovine Serum Albumin market revenue. This report conducts a complete Bovine Serum Albumin market review covering the main regions like North America, South America, Asia-Pacific, Europe, Middle-East, and Africa.
Initially, the Bovine Serum Albumin report presents the basic industry overview, Bovine Serum Albumin definition, product type and market presence. This report further lists the Bovine Serum Albumin deployment models, company profiles of major market players, demand, and supply scenario and the factors limiting the growth of Bovine Serum Albumin market. An in-depth analysis of forecast Bovine Serum Albumin market information will provide the data related to the Bovine Serum Albumin investment feasibility study. Bovine Serum Albumin forecast details related to market size, Bovine Serum Albumin consumer volume, manufacturing cost, the import-export scenario is studied in this report. Global Bovine Serum Albumin report portrays the business profile of leading players along with their Bovine Serum Albumin revenue, market growth, consumer base, and the business strategies followed by them. Also, the past data related to Bovine Serum Albumin market growth, market trends, manufacturing cost and Bovine Serum Albumin production volume are covered in this report.
Download Sample copy of Global Bovine Serum Albumin Market at https://market.biz/report/global-bovine-serum-albumin-market-hr/176265/#inquiry
Subdivisions of Global Bovine Serum Albumin Market
To get more knowledge about Bovine Serum Albumin industry, the report is segmented into top manufacturers, Bovine Serum Albumin market geographical regions, types, and applications. Top leading manufacturers drives the Bovine Serum Albumin market are Thermo Fisher Scientific Inc, Lampire Biological Laboratories, Kraeber & Co GmbH, Proliant Inc, Sigma-Aldrich Co (Merck KGaA) and Rocky Mountain Biologicals.
Global Bovine Serum Albumin Market covered main regions like North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Furthermore, product types and applications give the simplified view of Bovine Serum Albumin industry. Pharmaceutical Grade and Reagent Grade are the major types of Bovine Serum Albumin market and applications of Bovine Serum Albumin market categorized into Research Institutes, Pharmaceutical Industry and Diagnostic Industry.
Global Bovine Serum Albumin report will answer various questions related to Bovine Serum Albumin growth expected in the market segments, technological innovations, Bovine Serum Albumin market scope and details related to emerging market segments. This research evaluates the growth rate and Bovine Serum Albumin production value for each region like North America, South America, Europe, China, Japan, Middle-East, and Africa. Global Bovine Serum Albumin report then analyzes the market drivers, industry news, and Bovine Serum Albumin industry policies to provide the reader a complete view of the industry. A descriptive study of marketing channels, downstream buyers, Bovine Serum Albumin market share and region-wise SWOT analysis will forecast the market development. This report evaluates the potential buyers, Bovine Serum Albumin market position, gross margin analysis and the analysis of dependent market segments.
Try Sample copy of the Bovine Serum Albumin report at https://market.biz/report/global-bovine-serum-albumin-market-hr/176265/#requestforsample
Fundamentals of Global Bovine Serum Albumin Market
* Forecast information related to the Bovine Serum Albumin market size and growth, consumer base and emerging market segments are elaborated at depth in this Bovine Serum Albumin report.
* Region-wise Bovine Serum Albumin analysis will cover all the key factors related to revenue and Bovine Serum Albumin market share of the leading industry players.
* Analysis of growth opportunities, challenges, and barriers to the market development are covered in this report.
* An in-depth study of business profiles of the top Bovine Serum Albumin players along with their revenue, consumer volume will help in planning business strategies.
* Marketing strategies, emerging market segments and comprehensive analysis of Bovine Serum Albumin will lead to market development.
Thus, Global Bovine Serum Albumin Market report is an essential to guide for all the market aspirants like traders, distributors, manufacturers, suppliers and emerging market sectors.
Lampire – DelVal Reunion and Tailgate
Doylestown, PA – October 28, 2017
Lampire Biological Laboratories, Inc. and Delaware Valley University hosted a 40th Anniversary Reunion and Football Tailgate on Saturday, October 28, 2017 at the Delaware Valley University vs. Lebanon Valley College football game.
Lampire is pleased to have a long 40 year history with Delaware Valley University. To honor that history, Lampire President and CEO, Gregory F. Krug worked with DVU to coordinate the first combined corporate and alumni event at DVU. “It was a great day!” said Krug, “I am just happy we were able to bring together alumni who may not have seen each other for years. The stories we shared took me down memory lane. I hope that this model can be used by other corporations employing DVU alumni across the mid-atlantic region moving forward.” The day was a very emotional and moving experience for Greg.
Lampire was founded while Krug was an undergrad at then named, Delaware Valley College in 1977. Many of Krug’s professors and classmates helped the company early on and were significant in it’s development.
Over 50 alumni with ties to Lampire turned out for a beautiful fall day of football, memories and fun. In addition to the game, alumni were treated to lunch, event t-shirts, Lampire and DVU giveaways and raffle prizes. The group was treated to a visit by new DVU President, Dr. Maria Gallows. Both organizations appreciate all of the alumni who were able to make it out for the day!
DelVal Univ adds Gregory F. Krug, Pres/CEO, Lampire Biological Labs, to Board of Trustees
Oct 25, 2017
Delaware Valley University has announced it has added Gregory F. Krug, Class of 1977 to its Board of Trustees.
Krug is president and CEO of Lampire Biological Laboratories, Inc., a life sciences company he founded in 1977. Lampire has earned primary vendor status with biopharmaceutical, diagnostic, and medical device manufacturers worldwide. Lampire has six facilities in Pennsylvania and is considered one of the state’s top workforce development companies.
Krug is committed to providing students with opportunities to gain experience through internships that prepare them to move into careers in the life sciences. The company works with several universities and high schools in the area to encourage students to pursue STEM careers.
Lampire has provided antibodies used to develop cancer drugs and to detect heart attacks and strokes. The company has also developed and produced antibodies used in the detection of biological warfare. Lampire’s OMNI C3® Cell Culture Bag has been augmented by a menu of custom cell culture media following the acquisition in May 2017 of HB Custom Media. This new product line includes custom tissue culture media, reagents, supplements and animal embryo culture media for the Research Use Only (RUO) market for cell culture and the culturing of embryonic stem (ES) cells, both human and animal. Lampire continues to focus and expand its industry leadership in Bovine Serum Albumin (BSA) sales and marketing, adding new custom lyophilized and aqueous formulations to its product offerings. Lampire is actively engaged in the use of Lobster Hemocyanin as an immunology conjugate as a potential replacement for KLH as well as other cosmetic applications. Lampire will be intensely focused on work involving the development of animal vaccines.
Krug has a bachelor’s degree in Animal Science from Delaware Valley University. Other Trustee inductees include: Allen H. Child, Dr. Linda A. Detwiler, ’80, Andrew G. Dougherty, ’00 and the board’s first student representative, Julia Reynolds ’18 a Conservation and Wildlife Management major from Paramus, New Jersey.
Upper Bucks life sciences company bets on pharma
by Anthony Salamone –Contact Reporter, The Morning Call
One day in the late 1970s, Gregory Krug and some fellow student researchers were drawing blood from sheep at a Lancaster County farm, when a farmer made an offhand observation that inadvertently led to the founding of a company.
“We’re bleeding sheep out in Lancaster County,” said Krug, then an undergrad at Delaware Valley College near Doylestown. “We have a pitchfork in the ground with a lamp hanging because we didn’t have any electricity. And the farmer comes in. He’s looking … he strokes his beard and says, ‘You know what? You guys aren’t vampires; you’re lampires.’”
In that moment, life sciences company Lampire Biological Laboratories Inc. had found its name.
The company Krug helped found 40 years ago has since grown into a player in the life sciences field, with 130 employees spread out among six locations, including its headquarters in Bedminster Township, upper Bucks County; a laboratory in Coopersburg, and a 400-acre farm and laboratory in Everett, Bedford County. Lampire also recently acquired a Ben Franklin TechVentures startup based at Lehigh University, H.B. Custom Media Inc., in a deal that wil enhance the company’s ability to sell reagents used in stem cell therapy.
Lampire sells human and animal blood antibodies and related products, including serum and plasma, that are used in diagnostic testing by some of the world’s leading pharmaceutical and life science companies, Krug said. The privately held Lampire does not disclose financial information.
“What I tell people is we are to the life science industry what the coal mine is to the steel industry,” said Krug, 63.
And life sciences has become a big business in the Lehigh Valley and the state. Pennsylvania is a leader in the life science industry, according to the trade group Life Sciences Pennsylvania. Its most recent data, from 2014, says the industry contributes 77,000 employees, about 2,300 businesses and about $7 billion in local wages in Pennsylvania.
A study for Lehigh Valley Economic Development Corp. has identified life science research and manufacturing as one of four main industry-target sectors, based on such regional characteristics as proximity to markets and a highly skilled workforce.
Working with animals
Lampire began herding donkeys on a farm in Bedford County around 1989, after a Quakertown veterinarian suggested Krug move his menagerie of animals to a more rural area to avoid encroaching on development of farms in and around the Lehigh Valley.
The company has not looked back. Last year, the state Department of Community and Economic Development awarded Lampire a $199,500, low-interest loan to build a sheep barn that will enable the company to make large quantities of sheep “polyclonal antiserum” used in diabetes testing.
The company uses everything from donkeys, cows and pigs to alligators, hamsters and rats to develop its serums. The company draws blood from the animals, but deals with them humanely and does not prematurely euthanize them, Krug said.
Krug said many of the large farm animals come from sources where they might have been euthanized, but instead “live out their lives” at Lampire facilities.
The Bedminster Township headquarters, which is off Route 611, features lab clean rooms. For mice and other animals, there’s a specialized filtered-air system.
Small live animal supervisor Amanda Machin of Coopersburg recently demonstrated a process known as “harem breeding,” using mice for research inside a inside a small plastic box.
“There’s two females to one male, and they live as a family,” said Machin, who said the rodents tend to live about two or three years.
“We spoil them so they do live a bit longer,” she said.
While Krug said he has considered consolidating operations in Bedford County, he also said it’s not likely to happen.
“The locations here and in Everett have very distinct features and benefits,” said Lee Kandt, Lampire’s general manager. “There are different things that make it attractive for us to keep both locations.”
Promoting science
Barbara Bielska, biotechnology professor at Northampton Community College, said Krug and Lampire employees have helped with workshops at the college by promoting science, and made several “valuable suggestions” for the college’s biotechnology curriculum.
“This is nice company deeply rooted in the local community,” said Bielska, also noting that Lampire offers NCC students internships. For Krug, the internships can foster another generation of scientists or other technical professionals.
“This is my first lab experience outside of school labs,” said Evan Becker, a junior pre-med major at West Chester University who is interning with Lampire. “It’s a little overwhelming in that I didn’t know there were so many regulations and procedures.”
Wayne Barz, entrepreneurial services manager at Ben Franklin Technology Partners, also said Krug has referred several diagnostic or drug-development start-ups to the local Ben Franklin, which is a key mission of the Lehigh University-based business incubator.
“He’s a go-to guy whenever we have anybody related to the work he does,” Barz said.
Sal Salamone, CEO of Saladax Biomedical Inc., a Ben Franklin-based company and Lampire customer, agrees.
“He’s very customer focused; he really caters to his clients,” Salamone said of Krug. “He really finds out their needs and bends over backwards to treat clients well and respond to their needs,”
asalamone@mcall.com
610-820-6694
Get the inside scoop on the Lehigh Valley’s business scene on The Business Cycle, themorningcall.com/business.
Like us on Facebook: facebook.com/LVBizCycle.
Follow us on Twitter: @LVBizCycle.
LAMPIRE BIOLOGICAL LABORATORIES
Headquarters: 5185 Applebutter Road, off Route 611, Bedminster Township, Bucks County
Locations: Six in Pennsylvania, including a 40-acre farm/research facility in Ottsville, Bucks County; a 400-acre farm/research facility in Everett, Bedford County; and a Coopersburg laboratory
Employees: About 130
What it makes: Raw materials such as serums and antibodies, drawn from animals, that are used by the diagnostic, biotechnological and pharmaceutical industries. Its work is also used in academic, business, military and environmental applications
Animal species: Include alligator, cows, chickens, donkeys, emus, geese, goats, guinea pigs, hamsters, horses, llamas, mice, rabbits, rats, rooster, sheep, and others.
Quotable: “What I tell people is we are to the life science industry what the coal mine is to the steel industry.” President Gregory Krug
Copyright © 2017, Lehigh Valley Business Cycle
LAMPIRE Biological Labs acquires H.B. Custom Media
FOR IMMEDIATE RELEASE – May 9, 2017
Pipersville, PA:
LAMPIRE Biological Laboratories, Inc., announced it has completed the acquisition of H. B. Custom Media, based out of the Ben Franklin Tech Ventures Business Center, in Bethlehem, PA. The acquisition includes all equipment, materials and personnel.
LAMPIRE Biological Laboratories, Inc., is a provider of human and animal blood and blood products, OMNI C3 cell culture bags, monoclonal and polyclonal antibody development, manufacturing, and purification services and operates as a Critical Material Manufacturer for a number of fortune 500 companies and their subsidiaries. LAMPIRE offers clients a wide array of products and services fundamental in the fields of drug discovery, compound development and clinical and research diagnostics.
In complement, H. B. Custom Media Inc. (HBCM) is a supplier of custom tissue culture media, reagents, supplements and animal embryo culture media to the Research Use Only (RUO) market for cell culture and the culturing of embryonic stem (ES) cells, both human and animal. H. B. provides the research scientist with the ability to obtain high quality custom tissue culture media and reagents for a lower cost with faster turnaround times and personalized service than the competition.
“The addition of media production to our portfolio will not only augment our LAMPIRE product line, but will enhance our ability to provide industry-leading monoclonal antibody production and tissue culture services to our clients,” said Gregory F. Krug, President of LAMPIRE. “The synergy is clear, and this is a fantastic opportunity for us to continue to expand in this marketplace.”
Karen Hoskins, former CEO of H. B. Custom Media explained, “In order to grow, we needed to offer cGMP manufacturing and expand our infrastructure. Given LAMPIRE’s stature in the industry, it was an obvious choice for us.” The manufacturing of all H.B. Custom Media products will be consolidated to LAMPIRE’s Pipersville Biotechnology Center. Karen Hoskins has joined the LAMPIRE family as a Senior Operations Scientist, focused exclusively on the manufacturing and distribution of our newly released LAMPIRE Custom Media line of products.
The transition is expected to be completed by the beginning of June, 2017. Additionally, all H. B. products will be rebranded with the LAMPIRE name, including updates being made to the labeling, associated documentation and quality control standards.
“We’re enthusiastic and energized by everything happening at LAMPIRE” added Krug, “there are many exciting new things in 2017, and for a company entering its 40th year, continued improvement and growth is critical to our branding and reputation.”